Chromium picolinate shows promise for teen skin condition linked to insulin resistance
NCT ID NCT07371169
First seen Jan 31, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study tested whether a daily chromium picolinate supplement could reduce the severity of acanthosis nigricans (dark, thick skin patches) and improve insulin resistance in 90 adolescents aged 12-18. Participants took either the supplement or a placebo for 24 weeks, with regular check-ups to measure skin changes and insulin levels. The goal was to see if this simple supplement could help manage these linked conditions safely in teens.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baghdad Medical City / Children Welfare Teaching Hospital / Department of Endocrinology
Baghdad, Baghdad Governorate, 10045, Iraq
Conditions
Explore the condition pages connected to this study.